Clovis Oncology reported $91.52M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
Acadia Pharmaceuticals ACAD:US $ 168.21M 60.27M
Acorda Therapeutics ACOR:US $ 44.97M 5.73M
Agenus AGEN:US $ 65.49M 4.09M
Agios Pharmaceuticals AGIO:US $ 100.52M 1.24M
Anika Therapeutics ANIK:US $ 43.04M 2.79M
Arrowhead Research ARWR:US $ 105.32M 4.93M
Astrazeneca AZN:US 10.23B 280M
AstraZeneca AZN:LN 10.23B 280M
Cerulean Pharma CERU:US $ 8.4M 1.14M
Clovis Oncology CLVS:US $ 91.52M 6.92M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Enanta Pharmaceuticals ENTA:US $ 52.02M 544K
Esperion Therapeutics ESPR:US $ 71.22M 9.39M
GlaxoSmithKline GSK:LN 5.85B 1.13B
Halozyme Therapeutics HALO:US $ 118.3M 76.7M
Heron Therapeutics HRTX:US $ 77.13M 9.25M
Insmed INSM:US $ 153.54M 10.6M
Intrexon XON:US $ 27.07M 22.84M
Ligand Pharmaceuticals LGND:US $ 57.89M 4.39M
Merk MRK:US $ 9666M 666M
Mirati Therapeutics MRTX:US $ 182.57M 2.36M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Novartis NOVN:VX 10.86B 895M
Pfizer PFE:US $ 15640M 148M
Puma Biotechnology PBYI:US $ 47.52M 1.01M
Rigel Pharmaceuticals RIGL:US $ 42.78M 212K
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Seattle Genetics SGEN:US $ 630.61M 71.1M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
Veracyte VCYT:US $ 83.6M 566K
YTE INCY:US $ 656.97M 40.27M